Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Receivables (2020 - 2023)

Silo Pharma (SILO) has disclosed Receivables for 3 consecutive years, with $79200.0 as the latest value for Q3 2023.

  • Quarterly Receivables changed N/A to $79200.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $79200.0 through Sep 2023, changed N/A year-over-year, with the annual reading at $72020.0 for FY2022, N/A changed from the prior year.
  • Receivables hit $79200.0 in Q3 2023 for Silo Pharma, up from $68390.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $79200.0 in Q3 2023 to a low of $47000.0 in Q4 2020.
  • Historically, Receivables has averaged $66652.5 across 3 years, with a median of $70205.0 in 2022.